Actively Recruiting

Phase Not Applicable
Age: 40Years - 70Years
All Genders
NCT07538700

Hip-allograft In Proximal Humerus Fractures Versus Plate Implantation Alone: a Randomized Controlled Trial

Led by Tergooi Medical Center · Updated on 2026-04-20

56

Participants Needed

1

Research Sites

205 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Proximal humerus fractures (PHFs) are common osteoporotic fractures in adults and the elderly, leading to significant disability and reduced quality of life. Current treatment options for displaced PHFs include locking plate fixation (LCP) and various augmentation techniques, but there is no consensus on the optimal treatment. Although, femoral allografts have shown promising results, there is a need for more definitive evidence regarding the utilization of femoral graft augmentation in addition to locking plate fixation in 3- and 4-part PHFs. This study aims to evaluate the effectiveness of using a mushroom-shaped femoral allograft combined with LCP fixation compared to LCP fixation alone. We hypothesize that femoral allograft augmentation with LCP fixation will result in better clinical and functional outcomes than LCP fixation alone at 24 months post-operative

CONDITIONS

Official Title

Hip-allograft In Proximal Humerus Fractures Versus Plate Implantation Alone: a Randomized Controlled Trial

Who Can Participate

Age: 40Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients between 40 and 70 years old
  • Acute (less than 3 weeks) 3- or 4-part proximal humerus fracture (NEER classification)
  • Ability to understand and communicate in Dutch
  • Competent to make decisions
  • Willing and able to complete study procedures
  • Provide written informed consent
Not Eligible

You will not qualify if you...

  • Head-split fractures
  • Pathological fractures due to malignancy or metastases
  • Diagnosis of dementia, cognitive impairment, or residing in institutional care
  • Terminal illness
  • Convulsive disorders, collagen diseases, or other conditions affecting shoulder mobility
  • Active joint or systemic infection
  • History of prior surgery on the same shoulder
  • Previous fracture in the same shoulder
  • Psychiatric illness preventing informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tergooi Medical Center

Hilversum, Netherlands

Actively Recruiting

Loading map...

Research Team

D

Dominique C Baas, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here